Beruflich Dokumente
Kultur Dokumente
Ashok Leyland
BUY
INDUSTRY AUTOS Gaining ground in tough times
CMP (as on 24 July 2017) Rs 104 Ashok Leyland (AL) posted in-line revenue (-0.5% YoY Highlights of the quarter
to Rs 42.4bn) in 1Q, while margins (-410bps YoY, Market share trend: Domestic MHCV share increased
Target Price Rs 118 7.2%) came much below estimates. EBITDA at Rs by 370bps YoY to 34.7% in 1QFY18. In the LCV segment,
Nifty 9,966 3.1bn (-37% YoY) was hit by operating de-leverage market share expanded by 113bps YoY at 8%. Discounts
Sensex 32,246 (one-offs in employee costs and other expenses). have come off in 1QFY18 for AL in comparison to its
KEY STOCK DATA
peers. The company is gradually increasing its presence
Despite subdued 1QFY18, management has in states like UP, where predominantly Tata is a leader.
Bloomberg AL IN maintained 10-15% volume growth guidance in FY18, Bottom-line focus: AL has focussed on generating
No. of Shares (mn) 2,927 led by revival in mining and construction activities. better profitability and curtailing debt via reduction of
MCap (Rs bn) / ($ mn) 304 / 4,730 The company is confident of maintaining double-digit working capital and controlling costs. Management’s
6m avg traded value (Rs mn) 1,156 margin. The newly launched iEGR tech enabled focussed approach is paying off with market share gains
STOCK PERFORMANCE (%) vehicles are helping AL gain market share (cost of in the M&HCV segment and debt at zero level in FY17.
52 Week high / low Rs 110 / 74 SCR vehicles are expensive by Rs 20-30k). 65-70% of the BS-III inventory has been either
converted to BS-4 with retro fitment or sold in export
3M 6M 12M We maintain our positive stance, and expect ~11% market. Company is confident of clearing 100% BS-3
Absolute (%) 19.2 17.2 7.5 volume CAGR over FY17‐19E, led by expanding inventory over next 3-4 months. Currently, BS-4 dealer
Relative (%) 10.5 (0.5) (8.4) distribution network, strong product portfolio and inventory stands at 8-10 days while the company
SHAREHOLDING PATTERN (%) recovery in economic activity. We estimate EPS CAGR inventory is ~9k vehicles with tight control on operating
at 32% over FY17-19E, on account of operating working capital at 8 days.
Promoters 51.29
FIs & Local MFs 8.02
leverage benefit and reduction in interest cost. We Near-term outlook: Management has indicated weak
have SOTP based TP to Rs 118 (9x EV/EBITDA 19E + wholesales for Jul-17. We expect revival in 2H owing to
FPIs 22.20 pick up in mining and construction activities.
0.5x investment book). Maintain BUY.
Public & Others 18.49
Source : BSE
Financial Summary
(Rs mn) 1QFY18 1QFY17 YoY (%) 4QFY17 QoQ (%) FY16 FY17 FY18E FY19E
Net Sales 28,495 31,163 (8.6) 47,621 (40.2) 189,373 200,187 227,083 260,555
Abhishek Jain
EBITDA (adj.) 3,061 4,821 (36.5) 7,299 (58.1) 22,546 22,025 24,522 34,250
abhishekkumar.jain@hdfcsec.com
+91-22-6171-7320 APAT 1,238 2,908 (57.4) 4,762 (74.0) 3,795 11,923 14,271 21,448
Diluted EPS (Rs) 0.4 1.0 (57.4) 1.4 (69.0) 1.4 4.3 5.0 7.5
P/E (x) 76.0 24.2 20.7 13.8
Sneha Prashant EV / EBITDA (x) 13.3 13.2 11.7 8.1
sneha.prashant@hdfcsec.com RoE (%) 7.2 20.7 22.0 28.9
+91-22-6171-7336 Source: Company, HDFC sec Inst Research
HDFC securities Institutional Research is also available on Bloomberg HSLB <GO> & Thomson Reuters
ASHOK LEYLAND : RESULTS REVIEW 1QFY18
Page | 2
ASHOK LEYLAND : RESULTS REVIEW 1QFY18
Volume Assumptions
(in units) FY15 FY16 FY17 FY18E FY19E
Domestic MHCV 66,445 98,814 102,313 107,146 120,599
The company is targeting 10-
% YoY 28.2 48.7 3.5 4.7 12.6
15% volume growth in FY18
LCV 27,242 30,695 31,770 36,711 42,218
% YoY (6.0) 12.7 3.5 15.6 15.0
Domestic volumes 93,687 129,509 134,083 143,858 162,817
Management indicated capex
% YoY 15.9 38.2 3.5 7.3 13.2
of Rs 5bn annually for FY18E
Exports 11,218 10,948 10,979 12,296 14,510
% YoY 31.7 (2.4) 0.3 12.0 18.0
We have cut our margin
Total sales 104,905 140,457 145,062 156,154 177,327
estimates for FY18E to factor
% YoY 17.4 33.9 3.3 7.6 13.6
in weak 1QFY18 and sluggish
Source: SIAM, HDFC sec Inst Research
wholesale volumes in Jul-17
SOTP Valuation
Rs mn Value
Investments in the
EBITDA (on Dec-18E) 34,250
subsidiaries would be in
EV/EBITDA (x) 9.0
addition to regular capex, but EV from core business 308,246
it would be very small in Investments (0.5x Dec-18E BV) 12,008
quantum as profitability of Total EV 320,255
these companies are steadily Net Debt (16,973)
improving, so capex Equity value 337,228
requirement is not very high Target price (Rs) 118
Source: HDFC sec Inst Research
Page | 3
ASHOK LEYLAND : RESULTS REVIEW 1QFY18
ASP Improved Led By Price Hikes GM Witnessed Decline Owing To Weaker Mix
Gross margin/vehicle (Rs'000) Gross margin (%) - RHS
AL’s ASP improved due to Net ASP (in Rs '000) % YoY (RHS)
lower discounts and price hike 1,600 15 500 35.0
of 10-14% taken in Apr-17 for 1,500 450
30.0
GST transition and 1,400 10 400
transformation to BS-4 1,300 350 25.0
vehicles 1,200 5 300
1,100 250 20.0
1,000 - 200
15.0
900 150
Higher raw material costs and 800 (5) 100 10.0
lower volume (higher export
1QFY16
2QFY16
3QFY16
4QFY16
1QFY17
2QFY17
3QFY17
4QFY17
1QFY18
1QFY16
2QFY16
3QFY16
4QFY16
1QFY17
2QFY17
3QFY17
4QFY17
1QFY18
mix in 1QFY17) led to lower
gross margins
Source: Company, HDFC sec Inst Research Source: Company, HDFC sec Inst Research
EBITDAM Declined YoY Owing To Neg Oplev Product Mix Saw Shift In Favour Of LCV
EBITDA margin declined by EBITDA/Vehicle (Rs '000) EBITDA margin (%) - RHS MHCV LCV
410bps YoY because of 100%
200.0 14.0
19%
20%
20%
192bps and 142bps YoY
23%
23%
24%
24%
25%
30%
180.0
increase in employee costs 12.0 80%
160.0
and other expenses 140.0 10.0
120.0 60%
8.0
100.0
6.0
81%
80%
80%
80.0 40%
77%
77%
76%
76%
75%
70%
60.0 4.0
Share of MHCVs was lower in 40.0
2.0 20%
20.0
the mix due to transition to
- -
BS-4 vehicles and 0%
1QFY16
2QFY16
3QFY16
4QFY16
1QFY17
2QFY17
3QFY17
4QFY17
1QFY18
1QFY16
2QFY16
3QFY16
4QFY16
1QFY17
2QFY17
3QFY17
4QFY17
1QFY18
Source: Company, HDFC sec Inst Research Source: Company, HDFC sec Inst Research
Page | 4
ASHOK LEYLAND : RESULTS REVIEW 1QFY18
AL’s Market Share In Dom MHCV Increased YoY Tonnage Mix Turned Favourable YoY
Ashok Leyland Tata Motors VECV Others Upto 16T >16 - 25 MT > 25 MT (Rigid)
1QFY16
2QFY16
3QFY16
4QFY16
1QFY17
2QFY17
3QFY17
4QFY17
1QFY18
1QFY16
2QFY16
3QFY16
4QFY16
1QFY17
2QFY17
3QFY17
4QFY17
1QFY18
Source: SIAM, HDFC sec Inst Research Source: SIAM, HDFC sec Inst Research
Sep-16
Feb-17
Jan-16
Jan-17
Mar-16
Mar-17
Dec-15
Jun-16
Dec-16
Jun-17
Jul-16
Aug-16
Oct-16
Apr-16
May-16
Apr-17
May-17
Nov-16
FY14
FY15
FY16
FY17E
FY18E
FY19E
Source: SIAM, HDFC sec Inst Research Source: Company, HDFC sec Inst Research
Page | 5
ASHOK LEYLAND : RESULTS REVIEW 1QFY18
Peer Valuations
Mcap CMP Adj EPS (Rs/sh) P/E (x) EV/EBITDA (x) RoE (%)
Reco TP
(Rs bn) (Rs/sh) FY17 FY18E FY19E FY17 FY18E FY19E FY17 FY18E FY19E FY17 FY18E FY19E
Maruti Suzuki 2,282 7,555 BUY 8,478 242.9 272.4 353.3 31.1 27.7 21.4 21.9 19.0 14.5 23.2 22.4 26.3
Tata Motors 1,576 464 BUY 542 30.2 34.6 49.3 15.4 13.4 9.4 7.2 5.1 3.9 12.2 12.7 15.8
Bajaj Auto 820 1,389 BUY 1,556 56.6 75.8 86.4 24.5 18.3 16.1 13.8 11.5 9.1 14.4 17.5 17.7
M&M 818 2,827 BUY 3,296 132.3 143.2 167.4 21.4 19.7 16.9 15.4 13.4 11.1 25.3 23.4 24.7
Eicher Motors 782 28,844 BUY 31,934 624.3 804.9 1,010.0 46.2 35.8 28.6 33.7 26.6 21.5 39.4 38.9 39.3
Hero Motocorp 737 3,692 NEU 3,740 169.1 182.1 208.0 21.8 20.3 17.8 14.9 13.7 12.0 35.6 33.9 34.8
Ashok Leyland 304 104 BUY 118 4.3 5.0 7.5 24.2 20.7 13.8 13.2 11.7 8.1 20.7 22.0 28.9
Force Motors 54 4,100 BUY 5,186 137.3 154.2 241.2 29.9 26.6 17.0 20.1 17.4 11.4 11.4 11.5 15.8
SML Isuzu 17 1,140 BUY 1,325 43.4 48.2 66.2 26.3 23.7 17.2 15.6 13.7 10.2 16.9 16.5 20.0
Atul Auto 9 424 BUY 528 17.7 26.2 31.1 23.9 16.2 13.7 13.5 9.5 7.8 23.1 28.5 27.7
Source: Company, HDFC sec Inst Research
Page | 6
ASHOK LEYLAND : RESULTS REVIEW 1QFY18
Page | 7
ASHOK LEYLAND : RESULTS REVIEW 1QFY18
Page | 8
ASHOK LEYLAND : RESULTS REVIEW 1QFY18
RECOMMENDATION HISTORY
Date CMP Reco Target
Ashok Leyland TP 25-Jul-16 97 NEU 92
130
16-Sep-16 81 BUY 104
120 5-Oct-16 81 BUY 91
110 9-Nov-16 91 BUY 101
5-Dec-16 75 BUY 93
100
27-Jan-17 87 BUY 100
90 13-Apr-17 83 BUY 87
80 28-May-17 92 BUY 106
25-Jul-17 104 BUY 118
70
Rating Definitions
Apr-17
Sep-16
Feb-17
Jun-17
Jul-16
Jul-17
Mar-17
Dec-16
Oct-16
Aug-16
Nov-16
Jan-17
May-17
BUY : Where the stock is expected to deliver more than 10% returns over the next 12 month period
NEUTRAL : Where the stock is expected to deliver (-)10% to 10% returns over the next 12 month period
SELL : Where the stock is expected to deliver less than (-)10% returns over the next 12 month period
Page | 9
ASHOK LEYLAND : RESULTS REVIEW 1QFY18
Disclosure:
We, Abhishek Jain, MBA & Sneha Prashant, MBA, authors and the names subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect our views about the subject
issuer(s) or securities. HSL has no material adverse disciplinary history as on the date of publication of this report. We also certify that no part of our compensation was, is, or will be directly or indirectly related to
the specific recommendation(s) or view(s) in this report.
Research Analyst or his/her relative or HDFC Securities Ltd. does not have any financial interest in the subject company. Also Research Analyst or his relative or HDFC Securities Ltd. or its Associate may have
beneficial ownership of 1% or more in the subject company at the end of the month immediately preceding the date of publication of the Research Report. Further Research Analyst or his relative or HDFC Securities
Ltd. or its associate does not have any material conflict of interest.
Any holding in stock –No
HDFC Securities Limited (HSL) is a SEBI Registered Research Analyst having registration no. INH000002475.
Disclaimer:
This report has been prepared by HDFC Securities Ltd and is meant for sole use by the recipient and not for circulation. The information and opinions contained herein have been compiled or arrived at, based upon
information obtained in good faith from sources believed to be reliable. Such information has not been independently verified and no guaranty, representation of warranty, express or implied, is made as to its
accuracy, completeness or correctness. All such information and opinions are subject to change without notice. This document is for information purposes only. Descriptions of any company or companies or their
securities mentioned herein are not intended to be complete and this document is not, and should not be construed as an offer or solicitation of an offer, to buy or sell any securities or other financial instruments.
This report is not directed to, or intended for display, downloading, printing, reproducing or for distribution to or use by, any person or entity who is a citizen or resident or located in any locality, state, country or
other jurisdiction where such distribution, publication, reproduction, availability or use would be contrary to law or regulation or what would subject HSL or its affiliates to any registration or licensing requirement
within such jurisdiction.
If this report is inadvertently send or has reached any individual in such country, especially, USA, the same may be ignored and brought to the attention of the sender. This document may not be reproduced,
distributed or published for any purposes without prior written approval of HSL.
Foreign currencies denominated securities, wherever mentioned, are subject to exchange rate fluctuations, which could have an adverse effect on their value or price, or the income derived from them. In addition,
investors in securities such as ADRs, the values of which are influenced by foreign currencies effectively assume currency risk.
It should not be considered to be taken as an offer to sell or a solicitation to buy any security. HSL may from time to time solicit from, or perform broking, or other services for, any company mentioned in this mail
and/or its attachments.
HSL and its affiliated company(ies), their directors and employees may; (a) from time to time, have a long or short position in, and buy or sell the securities of the company(ies) mentioned herein or (b) be engaged in
any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or
lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions.
HSL, its directors, analysts or employees do not take any responsibility, financial or otherwise, of the losses or the damages sustained due to the investments made or any action taken on basis of this report,
including but not restricted to, fluctuation in the prices of shares and bonds, changes in the currency rates, diminution in the NAVs, reduction in the dividend or income, etc.
HSL and other group companies, its directors, associates, employees may have various positions in any of the stocks, securities and financial instruments dealt in the report, or may make sell or purchase or other
deals in these securities from time to time or may deal in other securities of the companies / organizations described in this report.
HSL or its associates might have managed or co-managed public offering of securities for the subject company or might have been mandated by the subject company for any other assignment in the past twelve
months.
HSL or its associates might have received any compensation from the companies mentioned in the report during the period preceding twelve months from t date of this report for services in respect of managing or
co-managing public offerings, corporate finance, investment banking or merchant banking, brokerage services or other advisory service in a merger or specific transaction in the normal course of business.
HSL or its analysts did not receive any compensation or other benefits from the companies mentioned in the report or third party in connection with preparation of the research report. Accordingly, neither HSL nor
Research Analysts have any material conflict of interest at the time of publication of this report. Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or
brokerage service transactions. HSL may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
Research entity has not been engaged in market making activity for the subject company. Research analyst has not served as an officer, director or employee of the subject company. We have not received any
compensation/benefits from the subject company or third party in connection with the Research Report.
HDFC securities Limited, I Think Techno Campus, Building - B, "Alpha", Office Floor 8, Near Kanjurmarg Station, Opp. Crompton Greaves, Kanjurmarg (East), Mumbai 400 042 Phone: (022) 3075 3400 Fax: (022)
2496 5066
Compliance Officer: Binkle R. Oza Email: complianceofficer@hdfcsec.com Phone: (022) 3045 3600
HDFC Securities Limited, SEBI Reg. No.: NSE-INB/F/E 231109431, BSE-INB/F 011109437, AMFI Reg. No. ARN: 13549, PFRDA Reg. No. POP: 04102015, IRDA Corporate Agent License No.: HDF 2806925/HDF
C000222657, SEBI Research Analyst Reg. No.: INH000002475, CIN - U67120MH2000PLC152193
Mutual Funds Investments are subject to market risk. Please read the offer and scheme related documents carefully before investing.
Page | 10
ASHOK LEYLAND : RESULTS REVIEW 1QFY18
HDFC securities
Institutional Equities
Unit No. 1602, 16th Floor, Tower A, Peninsula Business Park,
Senapati Bapat Marg, Lower Parel, Mumbai - 400 013
Board : +91-22-6171 7330 www.hdfcsec.com
Page | 11